| EW:Edwards Lifesciences Corp | | Charting | News | Options | |||||||||||||
| ||||||||||||||
| ||||||||||||||
| ||||||||||||||
0.59% $0.51
 Markets |
 Portfolio |
| |
| |
|
| |
|
|
|
|||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||
|
| Latest Story |
|
| Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It |
|
| BusinessWire |
|
Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families. The findings of this study, which identified a significant discrepancy between participant self-awareness and actual prevalence of heart disease and associated risk factors, were presented today during a late-breaking clinical trials session at the American College of Cardiology (ACC.24/WCC) and published simultaneously in The Journal of the American College of Cardiology. |
| Full Story → |
|
| Headline News |
|
| Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR |
| 2:00p ET March 11 '24 BusinessWire |
|
|
| Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference |
| 7:05a ET February 23 '24 BusinessWire |
|
|
| Edwards Lifesciences Reports Fourth Quarter Results |
| 4:15p ET February 6 '24 BusinessWire |
|
| More News → |
| ||
|
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
| April 19 '24. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Previous data from yesterday, April 18 '24. | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| Historical Price Performance | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Market data provided by 
News provided by   |
15.65% 
